VATE INNOVATE Corp.


$ 4.91 $ -0.09 (-1.8 %)    

Friday, 21-Nov-2025 11:15:46 EST
QQQ $ 596.75 $ 9.42 (1.6 %)
DIA $ 465.42 $ 5.95 (1.29 %)
SPY $ 664.32 $ 9.31 (1.42 %)
TLT $ 89.34 $ -0.32 (-0.36 %)
GLD $ 375.93 $ 1.92 (0.51 %)
$ na
$ 5.00
$ 4.90 x 100
$ 5.19 x 18
$ 4.91 - $ 4.91
$ 3.83 - $ 13.79
7,430
na
68.14M
$ 1.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 innovate-q3-eps-071-up-from-118-yoy-sales-347100m-up-from-242200m-yoy

Innovate (NYSE:VATE) reported quarterly losses of $(0.71) per share. This is a 39.83 percent increase over losses of $(1.18) pe...

 innovate-announces-medibeacons-transdermal-gfr-system-receives-nmpa-approval-in-china-plans-year-end-launch

•MediBeacon®Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patient...

 innovate-q2-eps-167-down-from-100-yoy-sales-24200m-down-from-31310m-yoy

Innovate (NYSE:VATE) reported quarterly losses of $(1.67) per share. This is a 267 percent decrease over earnings of $1.00 per ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION